Telix Pharmaceuticals (TLX) Raw Materials (2023 - 2024)

Telix Pharmaceuticals (TLX) has disclosed Raw Materials for 2 consecutive years, with $9.4 million as the latest value for Q4 2024.

  • Quarterly Raw Materials rose 87.81% to $9.4 million in Q4 2024 from the year-ago period, while the trailing twelve-month figure was $9.4 million through Dec 2024, up 87.81% year-over-year, with the annual reading at $9.4 million for FY2024, 87.81% up from the prior year.
  • Raw Materials for Q4 2024 was $9.4 million at Telix Pharmaceuticals, up from $5.0 million in the prior quarter.
  • The five-year high for Raw Materials was $9.4 million in Q4 2024, with the low at $5.0 million in Q4 2023.